Hospital or health organisation · founded 1970
Northside Hospital
Atlanta, United States · northside.com
- Citations, last 5 years
- 8 710
- Works, last 5 years
- 710
- h-index
- 144
- Scientists listed
- 51
- Grants since 2016
- 15
Grants received
2014–2025 · cooperative agreement · UG1
Georgia NCI Community Oncology Research Program (GA NCORP)
Guilherme Cantuaria · Northside Hospital · funded by National Institutes of Health
2014–2025 · cooperative agreement · UG1
Georgia NCI Community Oncology Research Program (GA NCORP)
Guilherme Cantuaria · Northside Hospital · funded by National Institutes of Health
2014–2025 · cooperative agreement · UG1
Georgia NCI Community Oncology Research Program (GA NCORP)
Guilherme Cantuaria · Northside Hospital · funded by National Institutes of Health
2014–2025 · cooperative agreement · UG1
Georgia NCI Community Oncology Research Program (GA NCORP)
Guilherme Cantuaria · Northside Hospital · funded by National Institutes of Health
2014–2025 · cooperative agreement · UG1
Georgia NCI Community Oncology Research Program (GA NCORP)
Guilherme Cantuaria · Northside Hospital · funded by National Institutes of Health
2014–2025 · cooperative agreement · UG1
Georgia NCI Community Oncology Research Program (GA NCORP)
Guilherme Cantuaria · Northside Hospital · funded by National Institutes of Health
2014–2025 · cooperative agreement · UG1
Georgia NCI Community Oncology Research Program (GA NCORP)
Guilherme Cantuaria · Northside Hospital · funded by National Institutes of Health
2014–2026 · cooperative agreement · UG1
Georgia NCI Community Oncology Research Program (GA NCORP)
Guilherme Cantuaria · Northside Hospital · funded by National Institutes of Health
2011–2024 · cooperative agreement · UG1
Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.
Asad Bashey · Northside Hospital · funded by National Institutes of Health
2011–2024 · cooperative agreement · UG1
Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.
Asad Bashey · Northside Hospital · funded by National Institutes of Health
2011–2024 · cooperative agreement · UG1
Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.
Asad Bashey · Northside Hospital · funded by National Institutes of Health
2011–2024 · cooperative agreement · UG1
Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.
Asad Bashey · Northside Hospital · funded by National Institutes of Health
2011–2024 · cooperative agreement · UG1
Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.
Asad Bashey · Northside Hospital · funded by National Institutes of Health
2011–2024 · cooperative agreement · UG1
Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.
Asad Bashey · Northside Hospital · funded by National Institutes of Health
2011–2024 · cooperative agreement · UG1
Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.
Asad Bashey · Northside Hospital · funded by National Institutes of Health